BeOne Medicines
Madeleine Melchior has extensive experience in regulatory affairs, currently serving as Associate Director and Team Lead for New Markets EMEA at BeiGene since April 2020. Previously held senior regulatory positions at Nestle Skin Health/Galderma from October 2015 to December 2019, focusing on global regulatory strategies for brand development in pharmaceuticals, cosmetics, and food supplements. Madeleine's career includes roles at Bayer and Actavis, where responsibilities encompassed lifecycle management of nutritional brands and regulatory activities across Nordic markets. Early experiences as a pharmacist and intern complement a strong academic background, including a Master of Science in Pharmacy from Uppsala University and a Master’s degree in Pharmacy from the University of Sydney.
This person is not in any teams
This person is not in any offices
BeOne Medicines
36 followers
BeOne Medicines is a global oncology company domiciled in Switzerland that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them.